ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)

Conditions:   Alopecia Areata;   Alopecia Universalis;   Alopecia Totalis Intervention:   Drug: ATI 502 0.46% Topical Solution Sponsor:   Aclaris Therapeutics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials